Letterlife

Letterlife is a startup that aims to address the gender-specific challenges in diagnosing and treating ADHD in girls and women. Founded in 2023 and based in Sweden, the company has received a €700.00K Pre Seed Round investment on 12 September 2023 from Icebreaker.vc and Tham Invest. The company's slogan, "The #1 Support for Women With ADHD," reflects its focus on providing support specifically tailored to the needs of this vulnerable and clinically significant group. Letterlife collaborates with patients, clinicians, and internationally recognized experts in epidemiology, gynecology, and female mental health to develop its solutions. Recognizing the delayed diagnosis and lack of adequate support for women with ADHD, Letterlife is committed to filling the gap in research, healthcare, and peer support for this underserved population. The company's efforts align with the pressing need to improve the quality of life for women with ADHD and their relatives by addressing the gender-related social bias and biological differences that contribute to delayed diagnosis and suboptimal treatment. By targeting an important but neglected segment of the healthcare industry, Letterlife demonstrates potential for significant impact and offers an innovative approach to addressing the unmet needs of women with ADHD. With its strong founding team, focus on a critical healthcare area, and early investor support, Letterlife is well-positioned to make a meaningful difference in the lives of women with ADHD.